Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Biotage AB
F:PQX1

Watchlist Manager
Biotage AB Logo
Biotage AB
F:PQX1
Watchlist
Price: 12.47 EUR
Market Cap: €989.5m
Write Note Create Alert Ask AI

Wall St Price Targets

PQX1 Price Targets Summary
Biotage AB

There are no price targets for PQX1.
PQX1 Lowest Forecast
Wall Street Target
Not Available
PQX1 Average Forecast
Wall Street Target
Not Available
PQX1 Highest Forecast
Wall Street Target
Not Available
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Biotage AB Competitors:
Price Targets
MRKR
Marker Therapeutics Inc
580% Upside
DVN
Devon Energy Corp
23% Upside
GLSI
Greenwich Lifesciences Inc
341% Upside
MRKR
Marker Therapeutics Inc
580% Upside
DVN
Devon Energy Corp
23% Upside
GLSI
Greenwich Lifesciences Inc
341% Upside

Revenue
Forecast

13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 8 years is 12%.

What are analyst estimates?

Gross Profit
Forecast

14% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
14% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%.

What are analyst estimates?

Operating Income
Forecast

23% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
23% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 8 years is 15%.

What are analyst estimates?

Pre-Tax Income
Forecast

21% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
21% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 21%.

What are analyst estimates?

Net Income
Forecast

18% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
18% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 18%.

What are analyst estimates?

Continue PQX1 Research

Summary
PQX1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
PQX1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PQX1 stock valuation using valuation multiples.
Wall St Estimates
PQX1 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PQX1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Biotage AB listings:
OTC • USD
BITGF
 LSE • SEK
0GRP
 STO • SEK
BIOT
 XMUN • EUR
PQX1
 SWB • EUR
PQX1
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PQX1's stock price target?
Not Available

PQX1 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Biotage AB?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 8 years is 12%.

What is the Operating Income forecast for Biotage AB?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 8 years is 15%.

Back to Top
ALPHA SPREAD
Follow us
Join 356,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett